SouthState Corp’s Insmed INSM Stock Holding History

SouthState Corp’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$747	Hold	7	–	–	﹤0.01%	1161
2026 Q1	$1.15K	Sell	7 -2	-22%	-$307	﹤0.01%	1017
2025 Q4	$1.57K	Buy	9 +2	+29%	+$365	﹤0.01%	1037
2025 Q3	$1.01K	Hold	7	–	–	﹤0.01%	1064
2025 Q2	$705	Buy	7 +1	+17%	+$76	﹤0.01%	1352
2025 Q1	$458	Buy	+6	New	+$459	﹤0.01%	1545

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

SouthState Corp's INSM Position: Q2 2026 in Review

SouthState Corp held its Insmed (INSM) position steady in Q2 2026 at 7 shares worth $747. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

SouthState Corp first reported a position in INSM in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.57K in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

SouthState Corp held 7 shares of Insmed worth $747 as of Q2 2026.
SouthState Corp left its Insmed share count unchanged in Q2 2026.
Insmed made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #1161 holding.
SouthState Corp first reported a position in Insmed in Q1 2025 and has held it in 6 quarters since.
SouthState Corp's Insmed position peaked at $1.57K in Q4 2025.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.